Incorporating molecular profiling into endometrial cancer management requires prospective studies.

Molecular profiling of endometrial carcinoma according to The Cancer Genome Atlas (TCGA) points toward a paradigm shift from morphological to molecular classification.[1][1] TCGA and many subsequent studies confirm the existence of four specific types of endometrial carcinoma: POLE ultramutated (±7